Comparing TR Band to Statseal in Conjunction With TR Band II

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 443 participants.

Also called NCT04046952

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 443 participants (enrolled count) (from the registry)
Sponsor
VA Long Beach Healthcare System (from the registry)
Registry
  • NCT NCT04046952
Other papers using this trial's data
  • Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch: The STAT2 Trial JACC. Cardiovascular interventions, 2022-04-25 DOI, PubMed 35450681

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04046952. Randomized; no masking; primary purpose treatment. Start 2019-10-10 (actual); primary completion 2020-12-15 (actual). Results posted on 2024-11-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing TR Band to Statseal in Conjunction With TR Band II
Acronym
Statseal II
Condition
Arterial Occlusion
Condition
Cardiovascular Diseases
Condition
Atherosclerosis
Condition
Hematoma
Condition
Anticoagulant-induced Bleeding
Intervention (Device)
Statseal with TR Band
Intervention (Device)
TR band only
Lead sponsor
VA Long Beach Healthcare System (class: US federal agency)

Record details

Record id
cardio:ct-nct04046952
Content hash
2d49afe947bd178aaf1348ebe84b8d6cf149d747435987e16c207efd4e117c3a